Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.
about
The diversity in the expression profile of caveolin II transcripts, considering its new transcript in breast cancer.Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.The TET enzymes.
P2860
Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells.
@ast
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells.
@en
type
label
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells.
@ast
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells.
@en
prefLabel
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells.
@ast
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells.
@en
P2093
P2860
P356
P1476
Novel Epigenetic Controlling o ...... of TET1 and TET2 in RPE Cells
@en
P2093
Farzaneh Sabouni
Saeed Solali
Zahra-Soheila Soheili
P2860
P304
P356
10.1002/JCB.25965
P577
2017-04-12T00:00:00Z